|
|
|
|
| LEADER |
01322nam a2200241 u 4500 |
| 001 |
EB002001076 |
| 003 |
EBX01000000000000001163977 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 245 |
0 |
0 |
|a Newborn individualized developmental care and assessment program--NIDCAP
|h Elektronische Ressource
|b early assessment of new health technologies
|c Swedish Council on Health Technology Assessment
|
| 260 |
|
|
|a Stockholm
|b Swedish Council on Health Technology Assessment (SBU)
|c 2006, 2006-06-07 [June 7, 2006]
|
| 300 |
|
|
|a 1 PDF file (3 pages)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 710 |
2 |
|
|a Statens beredning för medicinsk utvärdering (Sweden)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a SBU alert report
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK447964
|3 Volltext
|
| 082 |
0 |
|
|a 333
|
| 082 |
0 |
|
|a 361
|
| 082 |
0 |
|
|a 330
|
| 520 |
|
|
|a Conclusions The scientific evidence showing that NIDCAP has positive effects on cognitive and motor development in preterm infants is limited. Scientific grounds for assessing the effects of NIDCAP would be substantially enhanced by a sufficiently comprehensive study with extended follow-up and a clear focus on one or two important outcome variables
|